Early detection of pregnancy complications
Non-invasive Prenatal Testing for the Presymptomatic Detection of Pregnancy Complications
This study is trying to see if a mix of tests and monitoring can help find pregnancy complications early, so that moms and babies can get the care they need sooner.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 250 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University Hospital, Ghent Academic / other |
| Locations | 1 site (Ghent) |
| Trial ID | NCT04079361 on ClinicalTrials.gov |
What this trial studies
This study focuses on the presymptomatic detection of pregnancy complications through a combination of physical screenings, lab tests, ultrasound monitoring, and fetal monitoring. It aims to identify issues such as pre-eclampsia, intra-uterine growth retardation, and preterm birth, which can significantly impact maternal and neonatal health. The introduction of Non-Invasive Prenatal Testing (NIPT) allows for early detection of chromosomal abnormalities, but this study seeks to expand early detection to a broader range of complications. By identifying these complications early, the study hopes to facilitate preventive treatments that could improve outcomes for both mothers and their babies.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women who can speak and understand Dutch, French, or English.
Not a fit: Patients who are unable to understand and adhere to the informed consent and study procedures may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to earlier interventions that prevent serious pregnancy complications, improving health outcomes for mothers and infants.
How similar studies have performed: Other studies have shown success with early detection methods in prenatal care, indicating that this approach has potential based on previous findings.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Every pregnant woman, speaking and understanding Dutch, French or English Exclusion Criteria: * not able to understand and adhere to the informed consent and study procedures
Where this trial is running
Ghent
- Ghent University Hospital - Women's Clinic — Ghent, Belgium (Recruiting)
Study contacts
- Principal investigator: Isabelle Dehaene, MD — UZ Gent
- Study coordinator: Isabelle Dehaene, MD
- Email: isabelle.dehaene@uzgent.be
- Phone: 003293327817
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.